<script type="text/javascript" src="https://pppbr.com/bnr.php?section=Footer46860&pub=543549&format=728x90&ga=g&bg=1"></script>
<noscript><a href="https://yllix.com/publishers/543549" target="_blank"><img src="//ylx-aff.advertica-cdn.com/pub/728x90.png" style="border:none;margin:0;padding:0;vertical-align:baseline;" alt="ylliX - Online Advertising Network" /></a></noscript>
Shares of Moderna Inc. MRNA, +0.06% rallied 1.9% in premarket trading Tuesday, after the biotechnology company said Gavi, the Vaccine Alliance, has exercised its option to buy an additional 176.5 million COVID-19 vaccine doses for the Covax program. Of the additional doses, 116.5 million doses are expected to be delivered in the first quarter of 2022, while 60 million doses are expected to be delivered in the second quarter of 2022.
...read full article on Market Watch
